Source: Business Medical Dialogues

Avita Medical: AVITA Medical wins USFDA nod for conducting trial of Recell System for treating skin defects

AVITA Medical will initiate a prospective, Multi-center, randomized controlled study to compare the clinical performance of conventional skin grafting with and without the use of the RECELL System on acute non-burn full-thickness skin defects. Valencia: AVITA Medical, a regenerative medicine company focused on the development and commercialization of innovative therapies leveraging the healing properties of a patient's own skin, announced today that the U.S. Food and Drug Administration (FDA) has approved the company's Investigational Device Exemption (IDE) application to conduct a pivotal trial evaluating the safety and effectiveness of the

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Based on data from Avita Medical's latest SEC filings

Annual Revenue

Based on data from Avita Medical's latest SEC filings


Michael Perry's photo - CEO of Avita Medical


Michael Perry

CEO Approval Rating


Avita Medical is a medical device company that develops and markets respiratory and regenerative products for burns, sca... Read more